A citation-based method for searching scientific literature

James W Baurley, Christopher K Edlund, Carissa I Pardamean, David V Conti, Ruth Krasnow, Harold S Javitz, Hyman Hops, Gary E Swan, Neal L Benowitz, Andrew W Bergen. Nicotine Tob Res 2016
Times Cited: 24







List of co-cited articles
224 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Anu Loukola, Jadwiga Buchwald, Richa Gupta, Teemu Palviainen, Jenni Hällfors, Emmi Tikkanen, Tellervo Korhonen, Miina Ollikainen, Antti-Pekka Sarin, Samuli Ripatti,[...]. PLoS Genet 2015
74
79

Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
Yesha M Patel, Sunghim L Park, Younghun Han, Lynne R Wilkens, Heike Bickeböller, Albert Rosenberger, Neil Caporaso, Maria Teresa Landi, Irene Brüske, Angela Risch,[...]. Cancer Res 2016
39
62

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Delia Dempsey, Piotr Tutka, Peyton Jacob, Faith Allen, Kerri Schoedel, Rachel F Tyndale, Neal L Benowitz. Clin Pharmacol Ther 2004
313
50

Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
Gary E Swan, Christina N Lessov-Schlaggar, Andrew W Bergen, Yungang He, Rachel F Tyndale, Neal L Benowitz. Pharmacogenet Genomics 2009
65
50

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
Caryn Lerman, Robert A Schnoll, Larry W Hawk, Paul Cinciripini, Tony P George, E Paul Wileyto, Gary E Swan, Neal L Benowitz, Daniel F Heitjan, Rachel F Tyndale. Lancet Respir Med 2015
180
50

Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
Meghan J Chenoweth, Maria Novalen, Larry W Hawk, Robert A Schnoll, Tony P George, Paul M Cinciripini, Caryn Lerman, Rachel F Tyndale. Cancer Epidemiol Biomarkers Prev 2014
74
45

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
Robert A Schnoll, Freda Patterson, E Paul Wileyto, Rachel F Tyndale, Neal Benowitz, Caryn Lerman. Pharmacol Biochem Behav 2009
156
41

The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
Joseph Bloom, Anthony L Hinrichs, Jen C Wang, Linda B von Weymarn, Evan D Kharasch, Laura J Bierut, Alison Goate, Sharon E Murphy. Pharmacogenet Genomics 2011
63
37

Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
M Nakajima, T Yamamoto, K Nunoya, T Yokoi, K Nagashima, K Inoue, Y Funae, N Shimada, T Kamataki, Y Kuroiwa. J Pharmacol Exp Ther 1996
231
37

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
F Patterson, R A Schnoll, E P Wileyto, A Pinto, L H Epstein, P G Shields, L W Hawk, R F Tyndale, N Benowitz, C Lerman. Clin Pharmacol Ther 2008
131
37

Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
Meghan J Chenoweth, Jennifer J Ware, Andy Z X Zhu, Christopher B Cole, Lisa Sanderson Cox, Nikki Nollen, Jasjit S Ahluwalia, Neal L Benowitz, Robert A Schnoll, Larry W Hawk,[...]. Addiction 2018
26
37

Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Catherine A Wassenaar, Qiong Dong, Qingyi Wei, Christopher I Amos, Margaret R Spitz, Rachel F Tyndale. J Natl Cancer Inst 2011
134
33

Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
M K Ho, J C Mwenifumbo, N Al Koudsi, K S Okuyemi, J S Ahluwalia, N L Benowitz, R F Tyndale. Clin Pharmacol Ther 2009
121
33

Meta-analysis and imputation refines the association of 15q25 with smoking quantity.
Jason Z Liu, Federica Tozzi, Dawn M Waterworth, Sreekumar G Pillai, Pierandrea Muglia, Lefkos Middleton, Wade Berrettini, Christopher W Knouff, Xin Yuan, Gérard Waeber,[...]. Nat Genet 2010
477
33

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.
Thorgeir E Thorgeirsson, Daniel F Gudbjartsson, Ida Surakka, Jacqueline M Vink, Najaf Amin, Frank Geller, Patrick Sulem, Thorunn Rafnar, Tõnu Esko, Stefan Walter,[...]. Nat Genet 2010
521
29


Nicotine chemistry, metabolism, kinetics and biomarkers.
Neal L Benowitz, Janne Hukkanen, Peyton Jacob. Handb Exp Pharmacol 2009
738
29

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Li-Shiun Chen, A Joseph Bloom, Timothy B Baker, Stevens S Smith, Megan E Piper, Maribel Martinez, Nancy Saccone, Dorothy Hatsukami, Alison Goate, Laura Bierut. Addiction 2014
60
29

Role of human cytochrome P4502A6 in C-oxidation of nicotine.
M Nakajima, T Yamamoto, K Nunoya, T Yokoi, K Nagashima, K Inoue, Y Funae, N Shimada, T Kamataki, Y Kuroiwa. Drug Metab Dispos 1996
341
29

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Caryn Lerman, Rachel Tyndale, Freda Patterson, E Paul Wileyto, Peter G Shields, Angela Pinto, Neal Benowitz. Clin Pharmacol Ther 2006
202
29

Reproducibility of the nicotine metabolite ratio in cigarette smokers.
Gideon St Helen, Maria Novalen, Daniel F Heitjan, Delia Dempsey, Peyton Jacob, Adel Aziziyeh, Victoria C Wing, Tony P George, Rachel F Tyndale, Neal L Benowitz. Cancer Epidemiol Biomarkers Prev 2012
80
29

PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.
Ellen M McDonagh, Catherine Wassenaar, Sean P David, Rachel F Tyndale, Russ B Altman, Michelle Whirl-Carrillo, Teri E Klein. Pharmacogenet Genomics 2012
35
25

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Li-Shiun Chen, Rayjean J Hung, Timothy Baker, Amy Horton, Rob Culverhouse, Nancy Saccone, Iona Cheng, Bo Deng, Younghun Han, Helen M Hansen,[...]. J Natl Cancer Inst 2015
53
25

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.
C Lerman, C Jepson, E P Wileyto, F Patterson, R Schnoll, M Mroziewicz, N Benowitz, R F Tyndale. Clin Pharmacol Ther 2010
79
25

Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.
Mehmet Sofuoglu, Aryeh I Herman, Haleh Nadim, Peter Jatlow. Neuropsychopharmacology 2012
83
25

Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.
Julie-Anne Tanner, Maria Novalen, Peter Jatlow, Marilyn A Huestis, Sharon E Murphy, Jaakko Kaprio, Aino Kankaanpää, Laurence Galanti, Cristiana Stefan, Tony P George,[...]. Cancer Epidemiol Biomarkers Prev 2015
54
25

Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.
Sharon E Murphy, Sung-Shim L Park, Elizabeth F Thompson, Lynne R Wilkens, Yesha Patel, Daniel O Stram, Loic Le Marchand. Carcinogenesis 2014
99
20

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
Thorgeir E Thorgeirsson, Frank Geller, Patrick Sulem, Thorunn Rafnar, Anna Wiste, Kristinn P Magnusson, Andrei Manolescu, Gudmar Thorleifsson, Hreinn Stefansson, Andres Ingason,[...]. Nature 2008
20

Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.
Scott F Saccone, Anthony L Hinrichs, Nancy L Saccone, Gary A Chase, Karel Konvicka, Pamela A F Madden, Naomi Breslau, Eric O Johnson, Dorothy Hatsukami, Ovide Pomerleau,[...]. Hum Mol Genet 2007
629
20

Genome-wide meta-analyses of smoking behaviors in African Americans.
S P David, A Hamidovic, G K Chen, A W Bergen, J Wessel, J L Kasberger, W M Brown, S Petruzella, E L Thacker, Y Kim,[...]. Transl Psychiatry 2012
78
20


A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Tatsuki Fukami, Miki Nakajima, Ryoko Yoshida, Yuki Tsuchiya, Yuto Fujiki, Miki Katoh, Howard L McLeod, Tsuyoshi Yokoi. Clin Pharmacol Ther 2004
69
20

Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
Marc E Mooney, Zhong-Ze Li, Sharon E Murphy, Paul R Pentel, Chap Le, Dorothy K Hatsukami. Cancer Epidemiol Biomarkers Prev 2008
40
20

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Andrew W Bergen, Martha Michel, Denise Nishita, Ruth Krasnow, Harold S Javitz, Karen N Conneely, Christina N Lessov-Schlaggar, Hyman Hops, Andy Z X Zhu, James W Baurley,[...]. PLoS One 2015
14
28

The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations.
Yesha M Patel, Daniel O Stram, Lynne R Wilkens, Sung-Shim L Park, Brian E Henderson, Loic Le Marchand, Christopher A Haiman, Sharon E Murphy. Cancer Epidemiol Biomarkers Prev 2015
42
16

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.
Christopher I Amos, Xifeng Wu, Peter Broderick, Ivan P Gorlov, Jian Gu, Timothy Eisen, Qiong Dong, Qing Zhang, Xiangjun Gu, Jayaram Vijayakrishnan,[...]. Nat Genet 2008
938
16

Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
A Joseph Bloom, Timothy B Baker, Li-Shiun Chen, Naomi Breslau, Dorothy Hatsukami, Laura J Bierut, Alison Goate. Hum Mol Genet 2014
25
16

Variants in nicotinic receptors and risk for nicotine dependence.
Laura Jean Bierut, Jerry A Stitzel, Jen C Wang, Anthony L Hinrichs, Richard A Grucza, Xiaoling Xuei, Nancy L Saccone, Scott F Saccone, Sarah Bertelsen, Louis Fox,[...]. Am J Psychiatry 2008
466
16

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.
Nancy L Saccone, Robert C Culverhouse, Tae-Hwi Schwantes-An, Dale S Cannon, Xiangning Chen, Sven Cichon, Ina Giegling, Shizhong Han, Younghun Han, Kaisu Keskitalo-Vuokko,[...]. PLoS Genet 2010
281
16

Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
Masaki Fujieda, Hiroshi Yamazaki, Tetsuya Saito, Kazuma Kiyotani, Maxwell Afari Gyamfi, Masaharu Sakurai, Hirotoshi Dosaka-Akita, Yuichi Sawamura, Jun Yokota, Hideo Kunitoh,[...]. Carcinogenesis 2004
151
16

Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a Japanese population.
Natsuhiko Kumasaka, Masayuki Aoki, Yukinori Okada, Atsushi Takahashi, Kouichi Ozaki, Taisei Mushiroda, Tomomitsu Hirota, Mayumi Tamari, Toshihiro Tanaka, Yusuke Nakamura,[...]. PLoS One 2012
37
16

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
Miki Nakajima, Tatsuki Fukami, Hiroyuki Yamanaka, Eriko Higashi, Haruko Sakai, Ryoko Yoshida, Jun-Tack Kwon, Howard L McLeod, Tsuyoshi Yokoi. Clin Pharmacol Ther 2006
168
16

Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
A Joseph Bloom, Oscar Harari, Maribel Martinez, Pamela A F Madden, Nicholas G Martin, Grant W Montgomery, John P Rice, Sharon E Murphy, Laura J Bierut, Alison Goate. Hum Mol Genet 2012
31
16


Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure.
Marcus R Munafò, Maria N Timofeeva, Richard W Morris, David Prieto-Merino, Naveed Sattar, Paul Brennan, Elaine C Johnstone, Caroline Relton, Paul C D Johnson, Donna Walther,[...]. J Natl Cancer Inst 2012
128
16

Pharmacogenetics of nicotine and associated smoking behaviors.
Julie-Anne Tanner, Meghan J Chenoweth, Rachel F Tyndale. Curr Top Behav Neurosci 2015
33
16

Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
A Joseph Bloom, Sarah M Hartz, Timothy B Baker, Li-Shiun Chen, Megan E Piper, Louis Fox, Maribel Martinez, Dorothy Hatsukami, Eric O Johnson, Cathy C Laurie,[...]. Ann Am Thorac Soc 2014
30
16

Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2.
Jennifer J Ware, Xiangning Chen, Jacqueline Vink, Anu Loukola, Camelia Minica, Rene Pool, Yuri Milaneschi, Massimo Mangino, Cristina Menni, Jingchun Chen,[...]. Sci Rep 2016
32
16

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
Li-Shiun Chen, Timothy B Baker, Megan E Piper, Naomi Breslau, Dale S Cannon, Kimberly F Doheny, Stephanie M Gogarten, Eric O Johnson, Nancy L Saccone, Jen C Wang,[...]. Am J Psychiatry 2012
97
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.